SAN DIEGO - Dare Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
News Medical on MSN5d
NIH-supported clinical trial to test experimental treatment for dengueA clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.
A House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...
A recent paper published in Science magazine by researcher Blanca Barquera, Ph.D., professor of biological sciences at ...
Hosted on MSN1d
South Carolina AG Leads 18 States Investigating Fauci In COVID Response, Despite PardonA coalition of 18 state Attorneys General has sent a letter to Congressional leadership, urging further investigation into ...
A newly released document reveals that the US government, under the Biden administration, allocated over $40 million in ...
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is ...
Ky., issued subpoenas to 14 agencies from the outgoing Biden administration in his effort to continue investigating the ...
The trial will be sponsored and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH). The FDA’s action is a critical first step ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback